Litigation for ponatinib hydrochloride
✉ Email this page to a colleague
US Court Litigation for ponatinib hydrochloride
| Patent | Case Name | Docket | Date Filed | Date Terminated | Cause | Court | Jury Demand | Link To Docket |
|---|---|---|---|---|---|---|---|---|
| 11,192,895 | TAKEDA PHARMACEUTICALS AMERICA, INC. v. APOTEX, INC. | 2:21-cv-12998|D.N.J. | 2021-06-25 | 2023-02-08 | 35:271 Patent Infringement | District Court, D. New Jersey | None | ⤷ Start Trial |
| 11,192,895 | TAKEDA PHARMACEUTICALS AMERICA, INC. v. TEVA PHARMACEUTICALS, INC. | 2:22-cv-07454|D.N.J. | 2022-12-21 | 2023-08-29 | 35:271 Patent Infringement | District Court, D. New Jersey | None | ⤷ Start Trial |
| 11,192,895 | ⤷ Start Trial | 2:26-cv-08064|D.N.J. | 2026-07-01 | 35:271 Patent Infringement | District Court, D. New Jersey | None | ⤷ Start Trial | |
| >Patent | >Case Name | >Docket | >Date Filed | >Date Terminated | >Cause | >Court | >Jury Demand | >Link To Docket |
